Science & research

Prostate carcinoma

Tilly W, Gellermann J, Graf R, Hildebrandt B, Weissbach L, Budach V, Felix R, Wust P. Regional hyperthermia in conjunction with definitive radiotherapy against recurrent or locally advanced prostate cancer T3 pN0 M0. Strahlentherapie und Onkologie (2005) Jan;181(1):35-41. DOI: 10.1007/s00066-005-1296-8

Maluta S, Dall’Oglio S, Romano M, Marciai N, Pioli F, Giri MG, Benecchi PL, Comunale L, Porcaro AB. Conformal radiotherapy plus local hyperthermia in patients affected by locally advanced high risk prostate cancer: preliminary results of a prospective phase II study. International Journal of Hyperthermia (2007) Aug;23(5):451-6. DOI: 10.1080/02656730701553260

Kudzia R, Nahajowski D, Kukiełka AM, Dąbrowski T, Dybek D, Brandys P, Waligórski MP. Does microwave interstitial hyperthermia prior to high-dose-rate brachytherapy change prostate volume or therapy plan parameters? International Journal of Hyperthermia (2015) 31(5):568-73. DOI: 10.3109/02656736.2015.1033481.

Yahara K, Ohguri T, Yamaguchi S, Imada H, Narisada H, Ota S, Tomura K, Sakagami M, Fujimoto N, Korogi Y. Definitive radiotherapy plus regional hyperthermia for high-risk and very high-risk prostate carcinoma: Thermal parameters correlated with biochemical relapse-free survival. International Journal of Hyperthermia (2015) 31(6):600-8. DOI: 10.3109/02656736.2015.1062214.

HT Systems

Belgradzka street 5
02-793 Warszawa

+48 22 300 91 85

info@htsystems.com.pl

logo HT SYSTEMS

MODERN
MEDICINE IN FIGHT
WITH CANCER

Office hours:

Monday - Friday from 8:00 to 18:00